Metoprolol Aurobindo

Metoprolol Tartrate, the active ingredient in Metoprolol Aurobindo, is a beta blocker presented as oral tablets for oral use. It is used to lower high blood pressure, relieve chest pain from angina, and improve outcomes after heart attacks and in chronic heart failure. It is indicated for adults and is prescribed by physicians based on individual clinical assessment.

GNH USA supplies Metoprolol Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides regulatory‑approved batches for global distribution.

Metoprolol Aurobindo is used in cardiovascular conditions where β1‑adrenergic blockade improves outcomes.

- Hypertension: reduces systolic and diastolic blood pressure, helping patients reach target levels. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain during exertion. - Myocardial infarction: lowers the risk of recurrent ischemic events and improves survival after an acute heart attack. - Heart failure: diminishes heart rate and contractility, supporting ventricular function and reducing hospitalizations.

Metoprolol Aurobindo may cause a range of adverse reactions.

Common Side Effects: - Fatigue or tiredness. - Dizziness, especially when standing quickly. - Cold extremities such as hands and feet. - Gastrointestinal discomfort, including nausea or abdominal pain. - Mild depression or mood changes.

Serious or Rare Side Effects: - Severe bradycardia (abnormally low heart rate). - Hypotension leading to fainting or shock. - Heart block or worsening heart failure. - Bronchospasm in patients with asthma or COPD. - Allergic reactions such as rash, itching, or swelling.

Before initiating therapy, consider the following precautions.

- Cardiovascular assessment: evaluate heart rate, blood pressure, and cardiac function. - Concomitant beta‑blocker use: avoid duplicate therapy to prevent excessive β‑blockade. - Respiratory disease: use cautiously in patients with asthma or chronic obstructive pulmonary disease. - Diabetes: monitor blood glucose as beta‑blockade may mask hypoglycaemia symptoms. - Pregnancy and lactation: safety not established; weigh potential benefits against risks. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Metoprolol Aurobindo can interact with several medicines; monitoring is essential.

Major Interactions (Avoid): - Non‑selective beta‑blockers: additive cardiac depression. - Calcium channel blockers (e.g., verapamil, diltiazem): may cause severe bradycardia or heart block. - Antihypertensive agents (e.g., ACE inhibitors, diuretics): risk of profound hypotension.

Moderate Interactions (Monitor Closely): - Antidiabetic drugs: beta‑blockade can mask hypoglycaemia signs. - Antidepressants (e.g., SSRIs, tricyclics): may increase plasma metoprolol levels. - NSAIDs: can reduce antihypertensive efficacy. - CYP2D6 inhibitors (e.g., quinidine, fluoxetine): may raise metoprolol concentrations.